Sign in
CompletedPhase 2

CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes

Key facts

Who runs it
Medical University of South Carolina
Where
Charleston, United StatesSee the site
Trial code
Status
Completed
Phase
Phase 2
People taking part
46 people enrolled
Started
5 Dec 2023
Ended
5 Nov 2024
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Regular Nicotine patch and lozenge dose
  • Augmented Nicotine patch and lozenge dose
Record updated
26 November 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age 18yrs +
  • Daily nicotine-containing e-cigarette user (25+ days per previous month)
  • E-cigarette use 5+ times/day
  • E-cigarette use > 1year
  • Smoking >1 cigarette on 5-7 days per week
  • Interest in quitting smoking and e-cigarette within the next month (>7 on 10-point scale)
  • Willingness to use NRT
  • Able to receive text messages/email
  • Mailing address in South Carolina

Who cannot take part

  • Individuals reporting current use of other nicotine-containing products and/or smoking cessation medications
  • Medical conditions contraindicated to NRT use (including pregnancy, past month myocardial infarction, current cardiac arrhythmia, current angina, uncontrolled vascular disease, or medical conditions in which consumption of phenylalanine is contraindicated)
  • Those who vape non-nicotine substances
  • Individuals unable to consent (e.g. significant cognitive deficit, non-English speaking)

Where in United States

  • Medical University of South Carolina CharlestonCharleston, United States

About the trial

What the trial wants to find out

Many people smoke cigarettes and use e-cigarettes, and have a hard time stopping. Nicotine replacement therapy medications, such as nicotine patches and lozenges, have been shown to help people quit e-cigarette use. The purpose of the present study is to see how well nicotine patches and lozenges help people quit both smoking and vaping, and to determine if higher doses of the medication work best.

The 3 groups in the trial

  • Arm AExisting treatment, for comparison

    21mg patch, qd + 4mg lozenge prn \[minimum of 5 \& up to 20 per day\]

    Treatment: Regular Nicotine patch and lozenge dose

  • Arm BExisting treatment, for comparison

    21mg patch + 14mg patch qd + 4mg lozenge prn minimum of 5 \& \[up to 30 per day\]

    Treatment: Augmented Nicotine patch and lozenge dose

  • Arm CExisting treatment, for comparison

    2 x 21mg patches qd + 4mg lozenges prn \[minimum of 5 \& up to 40 per day\]

    Treatment: Augmented Nicotine patch and lozenge dose

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparing the Effects of Augmented Doses of Nicotine Replacement Therapy on Quitting Cigarettes and E-cigarettes
Publications
Record updated
26 November 2025